# A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

> **NCT02446028** · PHASE2 · SUSPENDED · sponsor: **Biodel** · enrollment: 13 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** BIOD-531
- **DRUG:** Humalog® Mix 75/25

## Key facts

- **NCT ID:** NCT02446028
- **Lead sponsor:** Biodel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2015-05
- **Primary completion:** 2016-02
- **Final completion:** 2016-05
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** IND Withdrawn
- **Last updated:** 2016-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446028, "A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02446028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*